Kenneth Hitchner

Kenneth Hitchner

Chairman at HH&L ACQUISITION CO.

Net worth: 647 426 $ as of 30/04/2024

63 year
Finance
Health Technology
Consumer Services

Kenneth Hitchner active positions

CompaniesPositionStartEnd
WUXI BIOLOGICS (CAYMAN) INC. Director/Board Member 09/06/2020 -
Independent Dir/Board Member 09/06/2020 -
HH&L ACQUISITION CO. Chairman 11/02/2021 -
CSTONE PHARMACEUTICALS Director/Board Member 10/12/2021 -
Chairman 14/02/2023 -
Chairman 02/05/2023 -

Career history of Kenneth Hitchner

Former positions of Kenneth Hitchner

CompaniesPositionStartEnd
PROT ACQU Director/Board Member 12/01/2021 28/10/2022
Independent Dir/Board Member 12/01/2021 28/10/2022
Chief Executive Officer 02/10/2013 12/07/2019
Chairman 02/10/2013 12/07/2019
President 02/10/2013 -
Chief Executive Officer 02/10/2013 12/07/2019
Chairman 02/10/2013 12/07/2019
THE GOLDMAN SACHS GROUP, INC. Corporate Officer/Principal 01/01/1991 01/01/2019
░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -

Training of Kenneth Hitchner

The University of Colorado Undergraduate Degree
Columbia Business School Masters Business Admin

Statistics

International

United States 6
Hong Kong 5
United Kingdom 3

Operational

Director/Board Member 5
Chairman 5
Chief Executive Officer 2

Sectoral

Finance 6
Health Technology 4
Consumer Services 3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies3
THE GOLDMAN SACHS GROUP, INC.

Finance

CSTONE PHARMACEUTICALS

Health Technology

WUXI BIOLOGICS (CAYMAN) INC.

Health Technology

Private companies8

Health Services

Finance

Health Technology

Finance

Health Services

Technology Services

Finance

Finance

See company connections